Biotechnology and pharmaceuticals

• Advising a UK pharma client on pharmaceutical distribution transactions in a number of overseas jurisdictions.
• Advising a listed global animal medicines business on a complex collaboration with a Spanish biotech business, involving the development and onward commercialisation of vaccine technology, and consideration of regulatory issues.
• Supporting an orphan drugs group on the development and commercialisation of its lead drug candidates, in particular, on its suite of supply chain, serialisation and market access agreements, a Phase III clinical trial programme, and the set-up of EU operations.
• Advising a Swiss-based biotech business on a range of technology in-licensing transactions.
• Advising on a large number of fundraisings (including IPOs) for a number of pharma and biotech clients.
• Supporting a Danish global pharma group on UK product compliance issues.
• Providing strategic HR support to a number of global pharma businesses.
• Advising a global pharma business on data compliance issues around a clinical trial.
• Advising a major university on the licensing of plant variety portfolios to a European industry partner.
• Advising Autolus on its relocation to former BBC base at White City in London.

Our clients include:

• Global organisations
• Fast-growing companies in a wide range of therapeutic areas 
• Universities involved in world-renowned research
• Leading research institutes
• Major research charities
• Government organisations
• Leading sector fund managers

We take our role within the industry seriously and offer advice through our Life Science Law blog, our Sequence Newsletter and our twitter feed @MRSequencelaw. 

We also contribute to Mills & Reeve's technology and GDPR articles. 

For the latest in-depth views on the legal implications of Brexit, visit our Brexit pages.